Ratification Date: 01/04/2025

Next Review Date: 01/04/2027

Interferon alfa – Metastatic renal cell carcinoma

Drug Name (Brand) Interferon alfa  (Roferon-A®, Viraferon®)
Indication Metastatic renal cell carcinoma
Traffic Light Classification Red
NICE TA (plus link)  
Further Information:

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

 

April 2013: NHS England SCG took over commissioning responsibility for this treatment.

 

 

 

 

Date of TAG recommendation / ratification 3/1/2006 Review Date 1/4/2027